Medetomidine hydrochloride |
![]() Last updated: 14/09/2025 |
![]() |
(Not known by any other names) |
|
![]() |
|
Medetomidine is a veterinary sedative analgesic often used in combination with opioids | |
---|---|---|
|
Used as both a surgical anesthetic and an analgesic | |
|
Deer; Cats; Dogs |
Approval status |
|
Approved - usually supplied as a prescription only medicine to be authorised by a veterinarian (POM-V) | |
---|---|---|
|
Approved |
Chemical structure |
|
Medetomidine hydrochloride exhibits chiral isomerism, as it contains a stereocentre in its molecular structure that gives rise to two enantiomers: dexmedetomidine and levomedetomidine. Only dexmedetomidine, the S-enantiomer, is pharmacologically active. However, medetomidine is commonly marketed as a racemic mixture of both enantiomers. | |
---|---|---|
|
C₁₃H₁₇ClN₂ | |
|
CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl | |
|
- | |
|
VPNGEIHDPSLNMU-UHFFFAOYSA-N | |
|
InChI=1S/C13H16N2.ClH/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13;/h4-8,11H,1-3H3,(H,14,15);1H | |
|
Yes |
|
![]() |
Common Name | Relationship | Link |
---|---|---|
medetomidine hydrochloride | - | ![]() |
General status |
|
Sedative, Analgesic | |
---|---|---|
|
Biocide | |
|
Unclassified substance | |
|
- | |
|
- | |
|
Synthetic | |
|
A non-narcotic alpha2-adrenoreceptor agonist | |
|
[Alpha2-adrenergic, Agonist] | |
|
86347-15-1 | |
|
- | |
|
None allocated | |
|
- | |
|
68601 | |
|
No data found | |
|
Nervous system: Psycholeptics | |
|
QN05CM91 | |
|
No | |
|
- | |
|
236.74 | |
|
- | |
|
5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole;hydrochloride | |
|
- | |
|
- | |
|
EU approval as antifouling agent until June 2026 | |
|
- | |
|
- | |
|
Commercial |
|
|
|||
---|---|---|---|---|
|
Current | |||
|
- | |||
|
|
|||
|
|
|||
|
Usually formulated as a solution for injection | |||
|
The production of medetomidine hydrochloride involves a multi-step synthetic process starting with 2,3-dimethylbromobenzene as the key precursor. This compound undergoes a Grignard reaction to form a tertiary alcohol intermediate, which is then subjected to dehydration and hydrogenation to yield the imidazole-based medetomidine structure. In one method, 5-[1-(2,3-dimethylphenyl)vinyl]-1H-imidazole is hydrogenated using palladium on activated carbon in methanol and water under controlled pressure and temperature, forming the ethyl-substituted imidazole core. After filtration and solvent removal, the crude product is treated with hydrochloric acid at low temperatures to precipitate medetomidine hydrochloride as a hydrate. | |||
|
Published GHG data is not available for most pharmaceuticals. However, according to industry, global averages suggest producing 1 kg of a typical active pharmaceutical ingredient can range from 10 to 100 kg CO₂e for small molecule drugs and potentially up to 1000 kg CO₂e for complex biologicals such as vaccines, depending on the drug type, its formulation, complexity of synthesis, solvent recovery, and energy sources used. |
|
![]() |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- |
Degradation |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below. | ||||||||||
|
- |
Soil adsorption and mobility |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
- | ||||||||||
|
- |
Fate indices |
|
|
|
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||||||||||||||||||||
|
|
- | - | - | |||||||||||||||||||||||||
|
- | - |
Known metabolites |
None
|
![]() |
Terrestrial ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
> 31.25 | E3 E = Manufacturers safety data sheets Rat3 = Unverified data of known source |
High | ||||||||
|
|
- | - | - | |||||||
|
- | - | |||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
- | |||||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - |
Aquatic ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - |
|
- | - | - | |||
|
- | - | - |
|
![]() |
General |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
High (class III) | - | - | ||||||||
|
> 31.25 | E3 E = Manufacturers safety data sheets Rat3 = Unverified data of known source |
High | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | |||||||||
|
- | ||||||||||
|
Metabolised and excreted via the kidneys in the urine. | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- |
Health issues |
|
|
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Possible lungs, liver and kidney toxicant May cause hypersensitivity reactions Harmful if swallowed Has a strong sedative effect |
Handling issues |
|
|
|||
---|---|---|---|---|
|
Emits a variety of toxic fumes on combustion Corrosive Not explosive or oxidising |
|||
|
Health: H300, H310 Environment: H400, H410 |
|||
|
Not listed (Not listed) | |||
|
Not regulated | |||
|
- | |||
|
- |
|
![]() |
|
|
||
---|---|---|---|
|
medetomidine hydrochloride | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- |
Record last updated: | 14/09/2025 |
Contact: | aeru@herts.ac.uk |
Please cite as: | Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242 |